Commercial Channels

Adds another acquisition, Dataline Software, to beef up real-world evidence (RWE) capabilities

As new cancer drugs with promising efficacy but brutal costs enter the market, providers, payers and manufacturers are strategizing new payment approaches

Leading copay-coupon provider expands its patient services with private equity help

Do you know your J codes?

Company uses online media to promote fill rates by more than 50%

1.5-10% improvement in 'revenue capture' is possible

'Stay tuned' for interactions directly with pharma companies, says CEO Jeff Tangney

Pharmacists' ranking, continuing a two-year decline, is now neck-and-neck with doctors

Acquisition builds on Dohmen's rare-disease business

Outsourced field sales is becoming only part of what CSOs are offering their pharma clients

Publicis Touchpoint Solutions does a deal with Cegedim Relationship Management

Compliance issues around sampling will be featured at upcoming conference

As rare diseases have emerged as a market opportunity for pharma over the past several years, industry practices are beginning to stabilize

After patent expires, 'The industry has turned a corner'

Siren Interactive hires more executives, moves to downtown Chicago

Real-world data sources can provide new dimensions to marketing plans

Latest ZS AccessMonitor asks, 'Who are physicians listening to?'

True 'market access' should involve coordinated approaches to patients and their healthcare providers

The eye-popping price tag on the hepatitis C drug, from Gilead Sciences, has prompted unprecedented pushback from payers

Company also announces a 10-year agreement with Salesforce.com

Service connects McKesson industry clients to PI's network of e-prescribing and EHRs

A rising flow of new, expensive therapies is transforming relationships among payers and providers. Manufacturers will have to react nimbly to the changes

J&J is the far-and-away leader in the IMS Health Social Media Engagement Index

Today's pharma marketers have the tools to refine their communication efforts to prescribers and patients

How new social health analytics tools are supercharging pharma's quest for patient insight